VP, Global Diversity, Equity, and Inclusion

Overview

Our Diversity, Equity and Inclusion team has been established with a clear vision and purpose since it was established in 2016. Though a small team, they have been highly adaptable and achieved remarkable positive impact across the organization. Through their unwavering dedication, passion and commitment, they have helped establish a safe and inclusive environment for colleagues globally.

The Vice President, Head of Global DE&I is a vital member of our HR Leadership team. This individual will be responsible for guiding our organization's journey in diversity, equity, and inclusion. They will empower our employees to support Alnylam's business growth by providing the right leadership, talent, and organizational capabilities.

This position requires a leader who can embed themselves in the business, working closely with a diverse group of colleagues from various Expertise Areas to ensure that the company's efforts toward diversity, equity, and inclusion remain authentic and aligned with Alnylam's core values and business needs. The responsibilities of this role include leading the cross-functional forum made up of  DE&I, Human Resources, and Corporate Responsibility Council, which oversees all key initiatives and activities to ensure they are in line with the company's vision and mission.

Key Responsibilities

• • Develop and lead a sustainable global DE&I program that aligns with the company's core values and DE&I vision and mission. Ensure alignment with the Executive Leadership Team to help foster DE&I throughout the organization
  • Collaborate with the Human Resources team to handle various aspects of employee management, such as hiring, training, equitable benefits, and employee relations. Additionally, work alongside stakeholders in Corporate Responsibility to engage with the community, Clinical Operations/Patient Advocacy to ensure clinical trial diversity, Legal, Compliance & Facilities to guarantee employee access and rights, and Expertise Area leaders to act as a role model and promote diversity, equity, and inclusion.
  • Lead and engage with the DE&I Leadership Teams in the US and OUS to drive DEI goals and manage budget
  • Support ERN Executive Sponsors and Leadership Teams to ensure the smooth operation of ERNs, providing leadership opportunities and appropriate rewards to employees who volunteer their time and effort on ERN activities.
  • Assist in leading and organizing significant global Diversity, Equity, and Inclusion (DE&I) events and celebrations.
  • Help with early diverse talent development activities and build on workforce development
  • Represent Alnylam externally with various organizations as a speaker to increase visibility and promote DE&I leadership.

Qualifications

• • Bachelor’s degree in arts, sciences, or communications
  • Seasoned, authentic leader in DE&I with a minimum of 5 years of leadership experience, ideally in biotech/life sciences
  • Ability to work with diverse and cross-functional groups of stakeholders at various levels within the organization and also externally to advocate for DE&I
  • Embodies Alnylam core values of commitment to people and open culture
  • Demonstrates leadership skills in making decisions, driving, organizing, and coordinating activities, often without direct authority
  • Shows good judgment in making decisions and navigating complex and sensitive external and internal issues with strong leadership, creativity, and personal engagement
  • Excellent listening and communication skills, demonstrating empathy and sensitivity to others in word and action
  • Willingness to advocate for change as appropriate
  • Ability to influence without direct authority
  • Ability to plan and manage budgets
  • Ability to speak, communicate, and promote our DEI vision and mission to a internal and external audiences

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.